Endpoints News 31 may 2026 #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study
BioPharma Dive 31 may 2026 ‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
Novartis 31 may 2026 Experimental Novartis radiopharma drug shows promise in early study - The Mighty 790 KFGO
Thermo Fisher 31 may 2026 Is Thermo Fisher (TMO) Turning AI-Enabled Orbitraps Into a Durable Edge in Life Sciences Tools? - simplywall.st
Endpoints News 31 may 2026 #ASCO26: Personalized cancer vaccines may help brain cancer patients live longer
Endpoints News 30 may 2026 #ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts say
BioNTech 30 may 2026 BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA - statnews.com
FierceBiotech 30 may 2026 In next-gen IO race in NSCLC, BioNTech/BMS and Pfizer are divided on overall survival approach
Pfizer 30 may 2026 ASCO: In next-gen IO race, BioNTech/BMS and Pfizer are divided on overall survival approach - Fierce Biotech
Illumina 30 may 2026 Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance
Illumina 30 may 2026 Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance Singapore
Cell 30 may 2026 Fronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation
FierceBiotech 30 may 2026 ASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’